Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Gain Therapeutics (NASDAQ:GANX) reported its Q1 earnings results on Monday, May 16, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Gain Therapeutics beat estimated earnings by 24.32%, reporting an EPS of $-0.28 versus an estimate of $-0.37.
Revenue was up $39.73 thousand from the same period last year.
Last quarter the company beat on EPS by $0.23 which was followed by a 7.28% drop in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Gain Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: GANX